中医定向透药治疗联合布地奈德雾化佐治支气管肺炎临床效果分析.docVIP

中医定向透药治疗联合布地奈德雾化佐治支气管肺炎的临床效果分析 　　[摘要]目的 探讨中医定向透药治疗联合布地奈德雾化佐治支气管肺炎的临床效果。方法 选取本院2013年10月～2016年10月收治的支气管肺炎患者196例，将其随机分为两组。对照组98例实施布地奈德雾化疗法，观察组98例实施中医定向透药治疗联合布地奈德雾化疗法。结果 治疗后，两组的C反应蛋白、白细胞计数、中医症状与体征积分降低，观察组治疗后的C反应蛋白、白细胞计数、中医症状与体征积分均低于对照组（P0.05）。结论 中医定向透药治疗联合布地奈德雾化佐治支气管肺炎的效果显著且安全性高。 　　[关键词]中医定向透药治疗；布地奈德；支气管肺炎；临床效果 　　[中图分类号] R563.1+2 [文献标识码] A [文章编号] 1674-4721（2018）2（b）-0145-03 　　Clinical effect analysis of Chinese medicine directional drug penetration therapy combined with Budesonide atomization treating auxiliarily bronchopneumonia 　　HUANG Xue-wei 　　Department of Pediatrics，Zhangmutou People′s Hospital of Dongguan City，Guangdong Province，Dongguan 523600，China 　　[Abstract] Objective To investigate clinical effect of Chinese medicine directional drug penetration therapy combined with Budesonide atomization treating auxiliarily bronchopneumonia.Methods 196 patients with bronchopneumonia treated in our hospital from October 2013 to October 2016 were selected and they were randomly divided into the two groups.98 patients treated Budesonide atomization were selected as the control group while 98 patients treated chinese medicine directional drug penetration therapy combined with Budesonide atomization were selected as the observation group.Results After treatment，C reactive protein，white blood cell count，TCM symptoms and signs integral were decreased in the two groups and the above-mentioned indexes in the observation group were all lower than those in the control group （P0.05）.Conclusion Chinese medicine directional drug penetration therapy combined with Budesonide atomization have significant effect in treatment for bronchopneumonia and high safety. 　　[Key words]Chinese medicine directional drug penetration therapy；Budesonide；Bronchopneumonia；Clinical effect 　　支?夤芊窝资且恢旨毙韵潞粑?道疾病，高发于婴幼儿[1-2]，具有起病急、病情进展快、病情重等特点，可严重危及患儿的生命安全。临床治疗中，西医用药较多，但易选择抗生素类药物，有可能导致各种耐药菌的产生，进而影响患儿的预后[3]。中医认为[4-5]，中药治疗在小儿支气管肺炎的治疗中发挥重要作用，但汤药本身的口感问题和小儿治疗依从性差等问题，会影响治疗效果，因而亟待寻求一种更有效的方法，在确保患儿药物疗效的同时，提高其配